Načítá se...
Protein Aggregation and Immunogenicity of Biotherapeutics
Recombinant proteins are the mainstay of biopharmaceuticals. A key challenge in the manufacturing and formulation of protein biologic products is the tendency for the active pharmaceutical ingredients to aggregate, resulting in irreversible drug loss, and an increase in immunogenicity risk. While th...
Uloženo v:
| Vydáno v: | Int J Pharm |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362938/ https://ncbi.nlm.nih.gov/pubmed/32531452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2020.119523 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|